Provided by Tiger Trade Technology Pte. Ltd.

Abeona Therapeutics

5.27
+0.10502.03%
Volume:379.45K
Turnover:1.99M
Market Cap:285.32M
PE:4.35
High:5.32
Open:5.24
Low:5.16
Close:5.16
52wk High:7.54
52wk Low:3.93
Shares:54.19M
Float Shares:38.26M
Volume Ratio:3.57
T/O Rate:0.99%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.21
EPS(LYR):-1.5527
ROE:75.90%
ROA:-29.57%
PB:1.67
PE(LYR):-3.39

Loading ...

Jan 10, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Dec 05, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 27, 2023

Major Issues Report

Form 8-K - Current report
Nov 13, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2023

Major Issues Report

Form 8-K - Current report
Oct 18, 2023

Major Issues Report

Form 8-K - Current report
Oct 10, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 08, 2023

Major Issues Report

Form 8-K - Current report
Aug 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 07, 2023

Major Issues Report

Form 8-K - Current report
Jul 06, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jul 03, 2023

Major Issues Report

Form 8-K - Current report
May 20, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 17, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Major Issues Report

8-K - Current report
May 11, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 11, 2023

Major Issues Report

8-K - Current report
Apr 10, 2023

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 29, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]